We always think of our customers with an open mind
Press Release
NTL participated in Yeongnam·Honam Obstetrics and Gynecology Society Academic Conference
Author
엔티엘헬스케어
Date
2023-06-21 10:43
Views
249
NTL, a specialized obstetrics and gynecology company, participated in the 31st Yeongnam·Honam Obstetrics and Gynecology Society Academic Conference and conducted promotional activities.
NTL Healthcare (CEO Tae-hee Kim) showcased the CerviCARE® AI, artificial intelligence image reading system, and the Dr. Cervicam® C20, cervical magnification imaging and reading system, at the 31st Yeongnam·Honam Obstetrics and Gynecology Society Academic Conference, held at Wonkwang University's WM Hall in Iksan, Jeollabuk-do on the 2nd."
The CerviCARE® AI is a reading system that allows users to check the results of cervical cancer screening in less than 5 seconds in outpatient clinics. NTL has accumulated big data for 27 years with the Korean Cervicography Conference, boasting a high accuracy. In December of last year, it received a Class 3 approval for obstetrics and gynecology clinical software from the Ministry of Food and Drug Safety. The introduction of CerviCARE® AI can be utilized as an auxiliary tool for medical treatment in university hospitals. The Dr. Cervicam® C20, cervical magnification imaging and reading system, boasts high resolution and is convenient to move around, making it versatile for various purposes.
In addition, CerviCARE® AI has completed approval from the Thailand Food and Drug Administration (TFDA) and is preparing to enter the Thailand market on the basis of this approval. It is also preparing to provide global services in Mongolia, Vietnam, Brazil, Costa Rica, and other countries.
NTL Healthcare (CEO Tae-hee Kim), said, "The artificial intelligence cervical cancer screening system is a system that allows women to receive safe and convenient cervical cancer screening, regardless of borders and regions. We plan to introduce various platforms focused on obstetrics and gynecology and women's diseases in addition to CerviCARE® AI."
Meanwhile, NTL Healthcare is planning to continue its promotional activities by participating in KOAMEX 2023, which will be held from June 30th to July 2nd.
NTL Healthcare (CEO Tae-hee Kim) showcased the CerviCARE® AI, artificial intelligence image reading system, and the Dr. Cervicam® C20, cervical magnification imaging and reading system, at the 31st Yeongnam·Honam Obstetrics and Gynecology Society Academic Conference, held at Wonkwang University's WM Hall in Iksan, Jeollabuk-do on the 2nd."
The CerviCARE® AI is a reading system that allows users to check the results of cervical cancer screening in less than 5 seconds in outpatient clinics. NTL has accumulated big data for 27 years with the Korean Cervicography Conference, boasting a high accuracy. In December of last year, it received a Class 3 approval for obstetrics and gynecology clinical software from the Ministry of Food and Drug Safety. The introduction of CerviCARE® AI can be utilized as an auxiliary tool for medical treatment in university hospitals. The Dr. Cervicam® C20, cervical magnification imaging and reading system, boasts high resolution and is convenient to move around, making it versatile for various purposes.
In addition, CerviCARE® AI has completed approval from the Thailand Food and Drug Administration (TFDA) and is preparing to enter the Thailand market on the basis of this approval. It is also preparing to provide global services in Mongolia, Vietnam, Brazil, Costa Rica, and other countries.
NTL Healthcare (CEO Tae-hee Kim), said, "The artificial intelligence cervical cancer screening system is a system that allows women to receive safe and convenient cervical cancer screening, regardless of borders and regions. We plan to introduce various platforms focused on obstetrics and gynecology and women's diseases in addition to CerviCARE® AI."
Meanwhile, NTL Healthcare is planning to continue its promotional activities by participating in KOAMEX 2023, which will be held from June 30th to July 2nd.
